Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2025 Earnings Call Transcript February 24, 2026 Kiniksa Pharmaceuticals, Ltd.

Good morning, ladies and gentlemen, and welcome to the freenet AG Conference Call on the Preliminary Results for the Financial Year 2025. At this time, all participants are on a listen-only mode. The ...

Phase III study will be "sufficient and pivotal for registration in the U.S." Kiniksa Pharmaceuticals ( KNSA +1.56%) ...

Q2 2026 Earnings Call February 25, 2026 3:00 AM ESTCompany ParticipantsHein Engelbrecht - COO, CEO & Executive ...

Official statistics, state rankings, common crimes, death rates & regional security explained comprehensively.

The Channel 4 factual drama, starring Jason Watkins and David Thewlis, delivers a damning indictment of the decline of ...

Xiang, H. and Tian, H. (2026) The Impacts of Bilateral Political Relations on Foreign Direct Investment: Evidence from China ...

UK CFOs want finance automation but 66% still use Excel. Compare Sage Intacct AI agents vs Dynamics 365 Finance Copilot — ...

Potential First and Only Therapy in the EU for Ultra-Rare Immune Disorder - BOSTON, Feb. 27, 2026 (GLOBE NEWSWIRE) -- X4 ...

Before we begin, I would like to remind everyone that this call will contain forward-looking statements. All statements made ...

BACKGROUND: Forecasts for the future prevalence of cardiovascular disease and stroke are crucial to guide efforts to improve health outcomes across the life course for women. METHODS: Using historical ...

Learn about impairment loss, its impact on assets, and how it is calculated when market value falls below book value in financial statements.